0
Kezar Life Sciences, Inc. Banner Image

Kezar Life Sciences, Inc.

  • Ticker KZR
    Exchange NASDAQ More
  • Industry Biotechnology More
  • Sector Healthcare More
Kezar Life Sciences, Inc. Logo Image
  • 11-50 Employees
  • Based in South San Francisco, California
Based in South San Francisco, Kezar Life Sciences is combining courage, conviction and cutting-edge science to develop breakthrough treatments for immune-mediated and oncologic disorders. The company is pioneering first-in-class, small-molecule therapies that harness master regulators of cellular function and inhibit multiple drivers of disease via a single target. KZR-616, a first-in-classMore selective immunoproteasome inhibitor, is being evaluated in severe and underserved autoimmune diseases. Additionally, KZR-261, the first clinical candidate for the treatment of cancer from the company’s protein secretion program targeting the Sec61 translocon, is undergoing IND-enabling activities.
Kezar Life Sciences, Inc.

Most Recent Annual Report

Kezar Life Sciences, Inc.
MOST RECENT 2021 Annual Report and Form 10K

Older/Archived Annual Reports